Search
forResearch 10 of 281
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
- TMPRSS2, required for SARS-CoV-2 entry, is downregulated in lung cells by enzalutamide, a prostate cancer therapeutic
- Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2
- Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Redefining hormone resistance in prostate cancer
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →